2018

04 November 2019

ALANTRA research 04/02/2019

04 November 2019

CFO SIM – PHARMANUTRA 2017 FY RESULT RELEASE 19/04/2018

31 October 2019

Internal Dealing 08/10/2018 ROBERTO LACORTE

31 October 2019

Internal Dealing 09/10/2018 ANDREA LACORTE

31 October 2019

REPORT ON THE 2017 FINANCIAL STATEMENTS AND CONSOLIDATED FINANCIAL STATEMENTS

31 October 2019

REPORT OF THE BOARD OF STATUTORY AUDITORS ON THE FINANCIAL STATEMENTS AT 31/12/2017

31 October 2019

Relazione illustrativa nomina Amministratore

31 October 2019

REPORT ON THE 31/12/2017 FINANCIAL STATEMENTS

31 October 2019

Report of the Board of Statutory Auditors on 2017 Pharmanutra Financial Statement

31 October 2019

Statutory financial statements 31/12/2017

31 October 2019

Modello delega per intervento assemblea aprile Pharmanutra

31 October 2019

Consolidated financial statements 31/12/2017

31 October 2019

Avviso di convocazione assemblea soci Pharmanutra

31 October 2019

PHARMANUTRA S.p.A.: PUBBLICATO AVVISO DI CONVOCAZIONE ASSEMBLEA ORDINARIA

24 October 2019

PHARMANUTRA GROUP STATUTORY FINANCIAL STATEMENT 31/12/2018

24 October 2019

PHARMANUTRA GROUP CONSOLIDATED FINANCIAL STATEMENTS 31/12/2018

24 October 2019

H1 FINANCIAL STATEMENTS 30/06/2018

20 December 2018

PharmaNutra signs an important agreement to distribute the Cetilar® line in Thailand

PharmaNutra s.p.A. is pleased to report that it has signed an important agreement for Cetilar® line products to be distributed […]

20 December 2018

PHARMANUTRA SIGNS AN IMPORTANT AGREEMENT TO DISTRIBUTE THE CETILAR® LINE IN THAILAND, OPENING UP THE SOUTH EAST ASIAN MARKET

14 December 2018

AIM Italy: PharmaNutra in the top 10 for performance and capitalisation

PharmaNutra S.p.A., a pharmaceutical company that leads the market in the iron-based nutritional supplements sector, listed on the AIM Market […]

14 December 2018

AIM ITALY: PHARMANUTRA IN THE TOP 10 FOR PERFORMANCE AND CAPITALISATION